This site limits showing results to the last 12 months. For full access, subscribe at CustomerGauge.com

NPS Intelligence (beta)

Disclosed NPS & retention by vertical

90
Latest disclosed NPS
21 Aug 2026
9
NPS entries
7 with a number
2025–26
Years covered
9 entries in all

In their words

“We helped health systems solve important operational challenges and achieve their patient care and market expansion goals. And patients love the care they receive, which is reflected in our Net Promoter Scores that consistently exceed 90.”
— Caitlin Zulla, Chief Executive Officer, Lumexa Imaging · Earnings call, Q2 2026 · 12 Aug 2026 · NI-5884F13
“I would like to take a moment to speak about our experience in the market as we meet with health systems and the providers who are so important to us and as we continue with our commercial efforts to drive growth in acuity mix. Our value proposition resonates strongly with patients, providers and payers, reflected in Net Promoter Scores that consistently exceed 90.”
— Caitlin Zulla, Chief Executive Officer, Lumexa Imaging · Earnings call, Q1 2026 · 13 May 2026 · NI-B085709
“I'd like to take a moment to reflect on the fundamentals of our business and the reason I believe we have a strong runway for continued growth. Our straightforward value proposition continues to resonate with patients, providers and payers as demonstrated by our high patient Net Promoter Scores, which are consistently over 90.”
— Caitlin Zulla, Chief Executive Officer, Lumexa Imaging · Earnings call, Q4 2025 · 2 Apr 2026 · NI-4916CA7

Disclosed NPS over time

Every Net Promoter Score Lumexa Imaging has published, by date.

8989.59090.59191.5922026NPS 91 · 17 Nov 202591NPS 91 · 2 Dec 202591NPS 91 · 30 Mar 2026NPS 90 · 2 Apr 202690NPS 90 · 13 May 202690NPS 90 · 12 Aug 2026NPS 90 · 21 Aug 202690
8989.59090.59191.5922026NPS 91 · 17 Nov 2025NPS 91 · 2 Dec 202591NPS 91 · 30 Mar 2026NPS 90 · 2 Apr 202690NPS 90 · 13 May 202690NPS 90 · 12 Aug 2026NPS 90 · 21 Aug 202690

NPS disclosures (9)

Search the database →

21 Aug 2026
NPS90

Lumexa Imaging reports Net Promoter Scores above 90 and record employee engagement.

— reported by tipranks.com · 21 Aug 2026 · NI-44707EE
tipranks.com ↗
12 Aug 2026
NPS90

We helped health systems solve important operational challenges and achieve their patient care and market expansion goals. And patients love the care they receive, which is reflected in our Net Promoter Scores that consistently exceed 90.

— Caitlin Zulla, Chief Executive Officer, Lumexa Imaging · Earnings call, Q2 2026 · 12 Aug 2026 · NI-5884F13
Earnings call, Q2 2026 ↗
1 Jun 2026
NPSProgram

Lumexa Imaging reports patient Net Promoter Scores consistently above 90, indicating high satisfaction and loyalty.

— reported by fool.com · 1 Jun 2026 · NI-93733B9
fool.com ↗
19 May 2026
NPSProgram

Lumexa Imaging reports net promoter scores that consistently exceed 90, reflecting strong value proposition resonance with patients, providers, and payers.

— reported by investing.com · 19 May 2026 · NI-1B5F35F
investing.com ↗
13 May 2026
NPS90

I would like to take a moment to speak about our experience in the market as we meet with health systems and the providers who are so important to us and as we continue with our commercial efforts to drive growth in acuity mix. Our value proposition resonates strongly with patients, providers and payers, reflected in Net Promoter Scores that consistently exceed 90.

— Caitlin Zulla, Chief Executive Officer, Lumexa Imaging · Earnings call, Q1 2026 · 13 May 2026 · NI-B085709
Earnings call, Q1 2026 ↗
2 Apr 2026
NPS90

I'd like to take a moment to reflect on the fundamentals of our business and the reason I believe we have a strong runway for continued growth. Our straightforward value proposition continues to resonate with patients, providers and payers as demonstrated by our high patient Net Promoter Scores, which are consistently over 90.

— Caitlin Zulla, Chief Executive Officer, Lumexa Imaging · Earnings call, Q4 2025 · 2 Apr 2026 · NI-4916CA7
Earnings call, Q4 2025 ↗
30 Mar 2026
NPS91

3 We contract with a third party to administer surveys to monitor referring physician and patient satisfaction with our quality of care. Our resulting patient net promoter score (“NPS”) was 91 and overall patient satisfaction rate was 97%, each as of December 31, 2025 and based on approximately 1.3 million survey responses.

— Lumexa Imaging · SEC 10-K annual report · filed 30 Mar 2026 · NI-0D8B56C
SEC 10-K annual report ↗
2 Dec 2025
NPS91

3 We contract with a third party to administer surveys to monitor referring physician and patient satisfaction with our quality of care. Our resulting patient net promoter score (“NPS”) was 91 and overall patient satisfaction rate was 97%, each as of September 30, 2025 and based on approximately 1.2 million survey responses.

— Lumexa Imaging · SEC S-1 IPO prospectus · filed 2 Dec 2025 · NI-06B67FF
SEC S-1 IPO prospectus ↗
17 Nov 2025
NPS91

3 We contract with a third party to administer surveys to monitor referring physician and patient satisfaction with our quality of care. Our resulting patient net promoter score (“NPS”) was 91 and overall patient satisfaction rate was 97%, each as of September 30, 2025 and based on approximately 1.2 million survey responses.

— Lumexa Imaging · SEC S-1 IPO prospectus · filed 17 Nov 2025 · NI-70C40A0
SEC S-1 IPO prospectus ↗

Retention disclosures (0)

Open in the retention database →

No retention figures yet.

Lighthouse companies in Pharma, medtech & health distribution

The whole vertical →

About these figures

Every figure here was publicly disclosed by the named company: press releases, annual reports, SEC filings, earnings calls and news coverage. Companies tend to publish their NPS when it is good, so these numbers run higher than a true industry average: read them as what leading companies in this vertical say publicly, not as an industry benchmark.

NPS runs from −100 to +100. Retention figures are reported as the company defines them (net revenue retention, gross revenue retention, customer retention rate, churn). Every entry links to its source in the full database.